Drug delivery device for gunshot wounds to hit market soon; Experts describe challenge of abuse-resistant controls;

> RevMedx will soon begin distributing its device for healing gunshot wounds to military medics and other nonmilitary markets. Story

> Developing abuse-resistant controlled-release mechanisms is a critical challenge, experts said in a detailed panel discussion about controlled-release drug delivery. Transcript

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.